Your browser doesn't support javascript.
loading
Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis.
Furtado, Vanessa Fiorini; Brauneis, Dina; Weinberg, Janice; Elhassan, Noon; Sloan, J Mark; Sanchorawala, Vaishali.
Afiliação
  • Furtado VF; Section of Hematology and Medical Oncology and Amyloidosis Center, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
  • Brauneis D; Section of Hematology and Medical Oncology and Amyloidosis Center, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
  • Weinberg J; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Elhassan N; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Sloan JM; Section of Hematology and Medical Oncology and Amyloidosis Center, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
  • Sanchorawala V; Section of Hematology and Medical Oncology and Amyloidosis Center, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA. Vaishali.Sanchorawala@bmc.org.
Bone Marrow Transplant ; 57(2): 306-308, 2022 02.
Article em En | MEDLINE | ID: mdl-34845368

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2022 Tipo de documento: Article